logo
  

China Approves SINOVAC's Sabin Strain Based Inactivated Polio Vaccine

SINOVAC Biotech Ltd. (SVA) said Monday it received a drug registration approval from the National Medical Product Administration of China or "NMPA" for its Sabin strain based inactivated polio vaccine or "sIPV".

The company expects that the vaccine will be available on the market by the end of 2021.

In addition, the company said it submitted an application for prequalification to the World Health Organization or "WHO" in early 2020 and the WHO conducted its on-site inspection in February 2021.

SINOVAC's sIPV is approved for use on infants and children aged 2 months and above to prevent poliomyelitis due to infection of types I, II and III polioviruses. The primary immunization requires 3 doses at least one month apart, beginning at 2 months of age. A booster shot will be given at 18 month of age.

According to the results of phase III clinical trial, no serious or rare adverse events were observed in relation to vaccinations, which indicates the good safety profile of SINOVAC's sIPV vaccine.

Inactivated polio vaccine contains no live virus and, thus, carries no risk of emergence from vaccine-derived poliovirus or vaccine-associated paralytic polio.

Poliomyelitis, commonly shortened to polio, is an infectious disease caused by the poliovirus, which mainly affects children under 5 years of age. Poliovirus is usually spread from person to person through infected fecal matter entering the mouth. It may also be spread through food or water containing human feces and, less commonly, from infected saliva, causing damage to motor neurons in the anterior horn of the spinal.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hormel Foods Corp. (HRL) said, in the fourth quarter, the company delivered earnings per share comparable with record results last year, which included an additional week of sales. Pretax earnings were $357 million, up 1% from a year ago. Organic net sales were up 2%, excluding the impact of an additional... Over the Thanksgiving holiday weekend, from Thanksgiving Day to Cyber Monday, around 196.7 million Americans shopped in stores and online, higher than the previous year, according to the National Retail Federation or NRF. Black Friday continued to be the most favored day for in-store as well as online shopping during the five-day holiday period. Lenoir, North Carolina -based Exela Pharma Sciences, LLC has expanded its recall of Sodium Bicarbonate Injection due to vial breakage to include more lots, the U.S. Food and Drug Administration said. The product is used for treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton.
RELATED NEWS
Follow RTT